Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

Recent Press Coverage

  1. PATH’s Nikolaj Gilbert and Dame Sally Davies write in The Telegraph about drug-resistant infections that are outpacing our ability to treat them—and how the global community must come together to address this growing global threat.
    Published: March 2025
  2. PATH is among the global partners receiving funding from the GHIT Fund’s $12.7 million investment to advance new diagnostics and drug development for malaria and neglected tropical diseases (NTDs).
    Published: January 2025
  3. Dr. Bilal Mateen, PATH’s Chief AI Officer, highlights GenAI’s potential in diagnostics, disease surveillance, and health communication while addressing challenges like data privacy and equity.
    Published: December 2024
  4. Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

952 Item s
952 Item s
    Date
    From
    To
  1. The newly updated HEROES Act not only proposes support for COVID-19 pandemic response in the United States, but also adds critical emergency funding for global health programs.
    Published: October 2020
    Press Release
  2. A grant from the GHIT Fund will support partners in the United States and Japan to develop a new low-cost, broad spectrum anthelmintic protein Cry5B oral treatment option.
    Published: September 2020
    Press Release
  3. Published: September 2020
    Press Release
  4. Clinical specimen bank now includes convalescent plasma, creating more opportunity for affordable diagnostic development
    Published: September 2020
    Press Release
  5. PATH, Innovax, KfW, and the Bill & Melinda Gates Foundation are partnering to expand options for human papillomavirus (HPV) vaccines in the countries that need them most.
    Published: August 2020
    Announcement